Gladstone Institutional Advisory LLC Has $1.75 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gladstone Institutional Advisory LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,361 shares of the medical equipment provider’s stock after selling 386 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in Intuitive Surgical were worth $1,754,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management increased its position in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its holdings in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its position in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ISRG shares. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $589.61 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market capitalization of $210.01 billion, a price-to-earnings ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. The firm has a fifty day moving average of $556.91 and a two-hundred day moving average of $516.98.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.